Mode
Text Size
Log in / Sign up
N/A Completed N=45

PortionSize Study 2 Free-Living Evaluation

Dietary Habits
Source: ClinicalTrials.gov NCT05166226 ↗
Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcomePrimary: Energy (Kilocalorie or kcal) Intake — 2128.8; 2120.0 kcal/day

Summary

The objective is to test the accuracy of the PortionSize™ app and the MyFitnessPal© app at measuring energy and nutrient intake in free-living conditions. Participants will use PortionSize™ and MyFitnessPal apps in separate periods to test the accuracy of the respective apps.

Outcome Measures

OutcomeResultp-value
PRIMARY
Energy (Kilocalorie or kcal) Intake
2128.8; 2120.0

Eligibility Criteria

Inclusion Criteria

Male or female, age 18-62 years

  • Body mass index (BMI) 18.5-50 kg/m2
  • Subjects who are capable of giving informed consent and complying with all study procedures/requirements.
  • Ownership of an iPhone model 6s or later, which the participant is willing to use for the study
  • Access to Apple ID, password, and email address and willing to use them during the study
  • Willing to use data and any accompanying charges as part of study participation
  • Willing to complete all study procedures and adhere to study visit timelines
  • Willing to be re-contacted for future research and/or follow-up

Exclusion Criteria

  • Active cancer diagnosis (excluding some melanomas)
  • Have been 6-month weight unstable (gain/loss >10 lbs in last 6 months)
  • Undergoing weight loss treatment
  • PBRC employee, as previous reviewers argued that they are not representative of the community
  • Women who are currently pregnant or breastfeeding (self-reported)
  • Diagnosed with an uncontrolled thyroid disorder (controlled = 3 months of medication)
  • Have had or plan to have weight loss surgery (gastric band removal may be allowed at PI discretion)
  • Allergic to or unwilling to eat study foods provided (exceptions made at the discretion of the PI)
  • Consume >28 alcoholic beverages per week
  • Anyone severely immunocompromised
  • Any condition or circumstance that in the judgement of the PI could interfere with study participation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05166226). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search